FTC Wins AndroGel Info From AbbVie In Antitrust Suit
A Pennsylvania federal judge on Thursday ordered AbbVie to hand over to the U.S. Federal Trade Commission documents from its board of directors concerning the marketing of testosterone treatment AndroGel in...To view the full article, register now.
Already a subscriber? Click here to view full article